Search Within

Ross Levine

Formats
  1. Journal Article (392)
  2. Meeting Abstract (348)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (11)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (786)
  2. Center for Hematologic Malignancies (786)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (786)
  4. Department of Medicine (786)
  5. Executive Committee, Center for Hematologic Malignancies (786)
  6. GSK Faculty (786)

More Groups

People
  1. Omar Abdel-Wahab (168)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (75)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (13)
  2. 2024 (36)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (293)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (316)
  2. Nature Publishing Group (109)
  3. American Association for Cancer Research (68)
  4. Cell Press (48)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (23)

More Publishers

Results (786)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High dose daunorubicin improves survival in AML up to age 60, across all cytogenetic Risk groups including patients with unfavorable cytogenetic risk, and FLT3-ITD mutant AML: Updated analyses from Eastern Cooperative Oncology trial E1900
    Meeting Abstract

    Luskin, M. R.; Lee, J. W.; Fernandez, H. F.; Lazarus, H. M.; Rowe, J. M.; Tallman, M. S.; Paietta, E. M.; Litzow, M.; Abdel-Wahab, O.; Patel, J. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Results of the ECOG E1900 trial in younger adults with AML using an event free survival endpoint are concordant with results based on overall survival: Potential for a surrogate endpoint to facilitate rapid approval of therapies in AML
    Meeting Abstract

    Luskin, M. R.; Lee, J. W.; Fernandez, H. F.; Lazarus, H. M.; Rowe, J. M.; Tallman, M. S.; Paietta, E. M.; Litzow, M.; Abdel-Wahab, O.; Patel, J. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Loss of TET2 function in myelodysplastic syndrome results in intragenic hypermethylation and alterations in mRNA splicing
    Meeting Abstract

    Lord, A. M.; Clement, K.; Schneider, R. K.; Marie, M.; Chen, M. C.; Levine, R. L.; Mullally, A.; Galili, N.; Ali, A. M.; Raza, A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Issues in categorization and management of pediatric patients with myeloproliferative neoplasms
    Meeting Abstract

    Kucine, N.; Levine, R. L.; Bussel, J. B.
    Blood (2014)

    Fulltext@MSK | Save
  • Patient derived xenograft (PDX) models recapitulate the genomic-driver composition of acute leukemia samples
    Meeting Abstract

    Krivtsov, A. V.; Wang, X. J.; Farnoud, N. R.; Hadler, M.; Martin, M. S.; Knapp, K. M.; Stein, E. M.; Lipson, D.; Nahas, M. K.; Stephens, P. J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genomic profiling combining DNA and RNA analysis of 112 formalin-fixed paraffin-embedded diffuse large B cell lymphoma specimens identifies a high frequency of clinically relevant genomic alterations
    Meeting Abstract

    Intlekofer, A. M.; Hilden, P.; Seshan, V. E.; Copeland, A. R.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Clinical utility of comprehensive profiling of genomic alterations in hematologic malignancies
    Meeting Abstract

    He, J.; Bufill, J. A.; Nahas, M. K.; Wang, K.; Young, L. E.; Knapp, K. M.; Brennan, K. W.; Donahue, A. L.; Young, G.; Ross, J. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Conditional loss of Dnmt3a results in myeloproliferation and liver-specific myeloid expansion
    Meeting Abstract

    Guryanova, O. A.; Lieu, Y.; Shank, K. R.; Rivera, S.; Garrett-Bakelman, F. E.; Glass, J.; Keller, M. D.; Pandey, S.; Tovbin, D.; Weinstein, A. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genomic analysis of serial samples from CLL patients identifies clonal events associated with disease progression
    Meeting Abstract

    Gardner, J. R.; Nahas, M.; He, J.; Aumann, S.; Gonen, M.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Minimal residual disease assessment by flow cytometry in AML is an independant prognostic factor even after adjusting for cytogenetic/molecular abnormalities
    Meeting Abstract

    Ganzel, C.; Sun, Z. X.; Gonen, M.; Patel, J. P.; Abdel-Wahab, O.; Fernandez, H. F.; Rowe, J. M.; Tallman, M. S.; Levine, R. L.; Paietta, E. M.
    Blood (2014)

    Fulltext@MSK | Save